L'Hôtel-Dieu de Québec
Hôtel-Dieu de Québec
11 Côte du Palais
Québec, QC
Canada G1R 2J6

Dernières nouvelles

Information non disponible

36 enregistrements « 1 de 4 »

Long GV, Robert C, Butler MO, Couture F, Carlino MS, O'Day S, Atkinson V, Cebon JS, Brown MP, Dalle S, Hill AG, Gibney GT, McCune S, Menzies AM, Niu C, Ibrahim N, Diab A, Moreno BH

Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules.

Article de revue

Clin Cancer Res, 2021.

Résumé | Liens:

Gambaro K, Marques M, McNamara S, Couetoux du Tertre M, Diaz Z, Hoffert C, Srivastava A, Hebert S, Samson B, Lesperance B, Ko YJ, Dalfen R, St-Hilaire E, Sideris L, Couture F, Burkes R, Harb M, Camlioglu E, Gologan A, Pelsser V, Constantin A, Greenwood CMT, Tejpar S, Kavan P, Kleinman CL, Batist G

Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer.

Article de revue

Clin Transl Med, 11 (4), 2021.

Résumé | Liens:

De Mattia E, Polesel J, Roncato R, Labriet A, Bignucolo A, Gagno S, Buonadonna A, D'Andrea M, Levesque E, Jonker D, Couture F, Guillemette C, Cecchin E, Toffoli G

IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm.

Article de revue

Cancers (Basel), 13 (7), 2021.

Résumé | Liens:

Meyerhardt JA, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Kumthekar P, Guthrie KA, Couture F, Kuebler P, Bendell JC, Kumar P, Lewis D, Tan B, Bertagnolli M, Grothey A, Hochster HS, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF

Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.

Article de revue

JAMA, 325 (13), 2021.

Résumé | Liens:

Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, Gallagher G, Kerr H, Kuruvilla J, Lee SJ, Moore J, Nevill T, Popradi G, Roy J, Schultz KR, Szwajcer D, Toze C, Foley R

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.

Article de revue

Lancet Haematol, 7 (2), 2020.

Résumé | Liens:

Chen EX, Jonker DJ, Loree JM, Kennecke HF, Berry SR, Couture F, Ahmad CE, Goffin JR, Kavan P, Harb M, Colwell B, Samimi S, Samson B, Abbas T, Aucoin N, Aubin F, Koski SL, Wei AC, Magoski NM, Tu D, O'Callaghan CJ

Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study.

Article de revue

JAMA Oncol, 6 (6), 2020.

Résumé | Liens:

Couture F, Finelli A, Tetu A, Bhindi B, Breau RH, Kapoor A, Kassouf W, Lavallee L, Tanguay S, Violette PD, Richard PO

Management of complex renal cysts in Canada: results of a survey study.

Article de revue

BMC Urol, 20 (1), 2020.

Résumé | Liens:

Waterhouse DM, Garon EB, Chandler J, McCleod M, Hussein M, Jotte R, Horn L, Daniel DB, Keogh G, Creelan B, Einhorn LH, Baker J, Kasbari S, Nikolinakos P, Babu S, Couture F, Leighl NB, Reynolds C, Blumenschein Jr, Gunuganti V, Li A, Aanur N, Spigel DR

Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.

Article de revue

J Clin Oncol, 38 (33), 2020.

Résumé | Liens:

Ruel S, Ivers H, Savard MH, Gouin JP, Lemieux J, Provencher L, Caplette-Gingras A, Bastien C, Morin CM, Couture F, Savard J

Insomnia, immunity, and infections in cancer patients: Results from a longitudinal study.

Article de revue

Health Psychol, 39 (5), 2020.

Résumé | Liens:

De Mattia E, Polesel J, Roncato R, Labriet A, Bignucolo A, Dreussi E, Romanato L, Guardascione M, Buonadonna A, D'Andrea M, Levesque E, Jonker D, Couture F, Guillemette C, Cecchin E, Toffoli G

Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI.

Article de revue

Front Oncol, 9 , 2019.

Résumé | Liens:

36 enregistrements « 1 de 4 »
Signaler des ajouts ou des modifications

Projets actifs

  • Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly diagnosed metastatic pancreatic adenocarcinoma: a feasibility and proof-of-concept study, du 2019-10-01 au 2021-09-30
Information provenant du registre des projets de recherche de l'Université Laval